Open-access biorepository for idiopathic pulmonary fibrosis: The way forward

Annals of the American Thoracic Society

Volumn 11, Issue 8, 2014, Pages 1171-1175

  White, Eric S ^a   Brown, Kevin K ^b   Collard, Harold R ^c   Conoscenti, Craig S ^d   Cosgrove, Gregory P ^b   Flaherty, Kevin R ^a   Leff, Jonathan A ^e   Martinez, Fernando J ^f   Roman, Jesse ^g   Rose, Dan ^h   Violette, Shelia ⁱ   Kaminski, Naftali ^j  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b DEPARTMENT OF MEDICINE   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d BOEHRINGER INGELHEIM PHARMACEUTICALS INC   (United States)

^e InterMune Inc ^*  (United States)

^f WEILL CORNELL MEDICAL COLLEGE   (United States)

^g University of Louisville School of Medicine   (United States)

^h Pulmonary Fibrosis Foundation   (United States)

ⁱ BIOGEN   (United States)

^j YALE UNIVERSITY   (United States)

more..

Author keywords

Biological specimen banks; Humans; Lung; Research priorities; Respiratory tract diseases

Indexed keywords

ARTICLE; BASIC RESEARCH; BLOOD; BRONCHOALVEOLAR SPACE; BRONCHUS; CLINICAL TRIAL (TOPIC); CONCEPTUAL FRAMEWORK; CULTURAL ANTHROPOLOGY; EXTRACELLULAR MATRIX; FIBROBLAST CULTURE; FIBROSING ALVEOLITIS; HEALTH CARE ACCESS; HEALTH CARE FACILITY; HEALTH CARE PLANNING; HUMAN; INFORMATION PROCESSING; INFORMED CONSENT; LUNG ALVEOLUS; LUNG ALVEOLUS EPITHELIUM; LUNG LAVAGE; LUNG PARENCHYMA; OPEN ACCESS BIOREPOSITORY; PLASMA; SCIENTIST; SERUM; STANDARDIZATION; TISSUE SECTION; TRANSLATIONAL RESEARCH; IDIOPATHIC PULMONARY FIBROSIS; INFORMATION SCIENCE; MEDICAL RESEARCH; ORGANIZATION AND MANAGEMENT; PROCEDURES; SPECIMEN HANDLING; TISSUE BANK; TRENDS;

BIOMEDICAL RESEARCH; HUMANS; IDIOPATHIC PULMONARY FIBROSIS; INFORMATICS; SPECIMEN HANDLING; TISSUE BANKS;

EID: 84912095592     PISSN: 23296933     EISSN: 23256621     Source Type: Journal    
DOI: 10.1513/AnnalsATS.201406-289OI     Document Type: Article

References (8)

1. Ramsey BW, Davies J, McElvaney NG, Tullis E, Bell SC, Dřevínek P, Griese M, McKone EF, Wainwright CE, Konstan MW, et al.; VX08-770-102 Study Group. A CFTR potentiator in patients with cystic fibrosis and the G551D mutation. N Engl J Med 2011;365:1663-1672.
2. King TE Jr, Bradford WZ, Castro-Bernardini S, Fagan EA, Glaspole I, Glassberg MK, Gorina E, Hopkins PM, Kardatzke D, Lancaster L, et al.; ASCEND Study Group. A phase 3 trial of pirfenidone in patients with idiopathic pulmonary fibrosis. N Engl J Med 2014;370:2083-2092.
3. Richeldi L, du Bois RM, Raghu G, Azuma A, Brown KK, Costabel U, Cottin V, Flaherty KR, Hansell DM, Inoue Y, et al.; INPULSIS Trial Investigators. Efficacy and safety of nintedanib in idiopathic pulmonary fibrosis. N Engl J Med 2014;370:2071-2082.
4. Schwiebert LM, Estell K, Meadows T, Thannickal VJ, Rowe S, Sorscher EJ, Harris WT, Gaggar A, Dransfield M, de Andrade JA. Development and maintenance of a biospecimen repository for clinical samples derived from pulmonary patients. Clin Transl Sci 2014;7:336-341.
5. Blackwell TS, Tager AM, Borok Z, Moore BB, Schwartz DA, Anstrom KJ, Bar-Joseph Z, Bitterman P, Blackburn MR, Bradford W, et al. Future directions in idiopathic pulmonary fibrosis research. An NHLBI workshop report. Am J Respir Crit Care Med 2014;189:214-222.
6. Collard HR, Moore BB, Flaherty KR, Brown KK, Kaner RJ, King TE Jr, Lasky JA, Loyd JE, Noth I, Olman MA, et al.; Idiopathic Pulmonary Fibrosis Clinical Research Network Investigators. Acute exacerbations of idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 2007;176:636-643.
7. Raghu G, Collard HR, Egan JJ, Martinez FJ, Behr J, Brown KK, Colby TV, Cordier JF, Flaherty KR, Lasky JA, et al.; ATS/ERS/JRS/ALAT Committee on Idiopathic Pulmonary Fibrosis. An official ATS/ERS/JRS/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management. Am J Respir Crit Care Med 2011;183:788-824.
8. Casaburi R, Celli B, Crapo J, Criner G, Croxton T, Gaw A, Jones P, Kline-Leidy N, Lomas DA, Merrill D, et al. The COPD Biomarker Qualification Consortium (CBQC). COPD 2013;10:367-377.